Lumina Datamatics recognized with the ET Now Best Organisations to Work 2025 Award
Mumbai (Maharashtra) [India], July 1: Lumina Datamatics, a strategic partner to global publishers and eCommerce retailers, is delighted to announce that it has been honored with the ET Now Best Organisations to Work 2025 Award on Wednesday, June 25, 2025, at Hotel Sahara Star in Mumbai. Lumina Datamatics was among the top 200 companies shortlisted for the honor out of 1,000 companies that participated, including marquee organizations such as Google India, HDFC Bank Limited, Wipro Limited, Tech Mahindra, Aditya Birla Capital Limited, Hindustan Unilever, Nestle India Limited and Britannia Industries among others.
This acknowledgment highlights Lumina Datamatics' ongoing commitment to cultivating a people-first culture founded on collaboration, empowerment, and professional development. The award celebrates organizations that demonstrate excellence in employee engagement and workplace culture.
Sameer Kanodia, Managing Director and CEO, Lumina Datamatics, and Vice Chairman and CEO, TNQTech, said, "We are truly honored to receive this recognition from ET Now. At the heart of our success is a team-driven culture that encourages innovation, inclusivity, and continuous learning. This award reaffirms our commitment to creating a workplace where every individual is valued, empowered, and inspired."
Being named among the "Best Organisations to Work" highlights Lumina Datamatics' unwavering commitment to building a strong workplace culture where every employee feels valued, empowered, and inspired to grow. This recognition is based on key parameters such as:
* Opportunities for career development
* A culture of inclusivity
* A safe environment
* Remarkable workforce management practices
* Special emphasis on employee engagement
The recognition reflects Lumina Datamatics' holistic approach to talent management and organizational development, underscoring its role as a progressive employer in the knowledge services and digital content space.
About Lumina Datamatics: Lumina Datamatics is a trusted partner in providing digital Content Services, Retail Support Services, and Technology Solutions to companies in the Publishing and Retail Industries worldwide. We are among the largest service providers in the Content space and our customers include nine of the ten largest Publishers and three of the five largest Retailers and Marketplaces. Lumina Datamatics' expert solutions combine its various in-house and client-facing platforms, partnerships with global technology leaders, and more than 6,500 professionals across the United States, the United Kingdom, Germany, Philippines, and India.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 days ago
- Time of India
Small cars and two-wheelers face demand pain: Sudip Bandyopadhyay
Tired of too many ads? Remove Ads ET Now: Let us talk about the auto space because today all eyes have been on the entire auto sales numbers. So far, we have numbers coming in from a lot of players and so far, the only thing that we seeing below estimates as of now is the M&M tractor segment and what has beaten estimates is M&M Auto, Ashok Leyland, TVS Motors, and Tata Motors CV. So, largely mixed set of numbers coming in so far because a lot of them are in line as well. What is your take on the kind of auto sales numbers we have seen and how have they fared versus your expectations? ET Now: Why we are talking about pharma, Sharan just said that Trump is actually doing everything he has promised and earlier he has also at least warned the street about a 200% of tariff. To what extent do you think that could actually turn to fruition, anything that can happen on that front, where are you seeing the impact on our pharma sector back home? Sudip Bandyopadhyay, Group Chairman, Inditrade Capital , says the small cars as well as two-wheeler there is a challenge, and we know that, there was a demand constraints and everybody was talking about that. We are hoping that festive season, post monsoon things will pretty much it is in line with the expectation I would say, at least that is what we were pencilling in. We were reasonably sure that the commercial vehicle numbers would be in line and better and improving and that is pretty much what the Ashok Leyland numbers shows. Even if you look at Eicher Motors , their commercial vehicle part does show promise and improvement. As far as domestic two-wheeler sales are concerned, obviously, it is subdued. Look at the Bajaj numbers. They are really bad. Of course, Bajaj has a fantastic export performance which takes care and that is why the overall numbers for Bajaj still looks better. But the small cars as well as two-wheeler there is a challenge, and we know that, there was a demand constraints and everybody was talking about that. We are hoping that festive season, post monsoon things will improve. We will have to wait and watch, that is pretty much what it is. As things stand today, there is a problem as far as demand for small cars as well as two one thing is very sure that as long as Mr Trump is the president, volatility is the order of the day and we have to be bracing ourselves for that. Every day there is something new and some new tweet comes in or some communication, an interview comes in which kind of rattles the market and that is the order of the day. As far as pharma is concerned, putting a tariff 200% or otherwise is not a viable proposition for us and the consumers which Trump is trying to protect. So, he will not venture there. But yesterday's and today's initiative where he has written to the pharma company CEOs to bring down the prices in US, that is a threat definitely and some of the Indian companies who have large business in US definitely will be impacted. If he carries out some other measure, some other punitive measure, or some other steps he takes to ensure that his communication is adhered to, that is a matter of big concern and worry. So, under these circumstances, and this view I have been maintaining for some time, it is better to be a little careful about companies having significant exposure in the US market and focus on companies who have less or no exposure as far as US markets are concerned. So, we were just talking about Mankind Pharma , that is one company which has got 95% of the sales in India and results were decent. So, one can focus on companies like this who have got a significant domestic presence and limited US presence.
Economic Times
3 days ago
- Economic Times
Small cars and two-wheelers face demand pain: Sudip Bandyopadhyay
ET Now: Let us talk about the auto space because today all eyes have been on the entire auto sales numbers. So far, we have numbers coming in from a lot of players and so far, the only thing that we seeing below estimates as of now is the M&M tractor segment and what has beaten estimates is M&M Auto, Ashok Leyland, TVS Motors, and Tata Motors CV. So, largely mixed set of numbers coming in so far because a lot of them are in line as well. What is your take on the kind of auto sales numbers we have seen and how have they fared versus your expectations? ET Now: Why we are talking about pharma, Sharan just said that Trump is actually doing everything he has promised and earlier he has also at least warned the street about a 200% of tariff. To what extent do you think that could actually turn to fruition, anything that can happen on that front, where are you seeing the impact on our pharma sector back home? (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Sudip Bandyopadhyay, Group Chairman, Inditrade Capital , says the small cars as well as two-wheeler there is a challenge, and we know that, there was a demand constraints and everybody was talking about that. We are hoping that festive season, post monsoon things will pretty much it is in line with the expectation I would say, at least that is what we were pencilling in. We were reasonably sure that the commercial vehicle numbers would be in line and better and improving and that is pretty much what the Ashok Leyland numbers shows. Even if you look at Eicher Motors , their commercial vehicle part does show promise and improvement. As far as domestic two-wheeler sales are concerned, obviously, it is subdued. Look at the Bajaj numbers. They are really bad. Of course, Bajaj has a fantastic export performance which takes care and that is why the overall numbers for Bajaj still looks better. But the small cars as well as two-wheeler there is a challenge, and we know that, there was a demand constraints and everybody was talking about that. We are hoping that festive season, post monsoon things will improve. We will have to wait and watch, that is pretty much what it is. As things stand today, there is a problem as far as demand for small cars as well as two one thing is very sure that as long as Mr Trump is the president, volatility is the order of the day and we have to be bracing ourselves for that. Every day there is something new and some new tweet comes in or some communication, an interview comes in which kind of rattles the market and that is the order of the day. As far as pharma is concerned, putting a tariff 200% or otherwise is not a viable proposition for us and the consumers which Trump is trying to protect. So, he will not venture there. But yesterday's and today's initiative where he has written to the pharma company CEOs to bring down the prices in US, that is a threat definitely and some of the Indian companies who have large business in US definitely will be impacted. If he carries out some other measure, some other punitive measure, or some other steps he takes to ensure that his communication is adhered to, that is a matter of big concern and worry. So, under these circumstances, and this view I have been maintaining for some time, it is better to be a little careful about companies having significant exposure in the US market and focus on companies who have less or no exposure as far as US markets are concerned. So, we were just talking about Mankind Pharma , that is one company which has got 95% of the sales in India and results were decent. So, one can focus on companies like this who have got a significant domestic presence and limited US presence.
Time of India
5 days ago
- Time of India
Maruti Suzuki shares in focus after Q1 beat estimates. Should you buy, sell, or hold?
Maruti Suzuki posted a marginal 0.9% YoY rise in consolidated net profit to Rs 3,792 crore for Q1FY26, with revenue growing 8% to Rs 38,605 crore. On a standalone basis, profit and revenue beat ET NOW estimates, while EBITDA came in higher at Rs 3,996 crore. The performance reflects resilience despite cost pressures and modest top-line growth. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads What should investors do? Here's what brokerages say Nuvama Avendus Shares of Maruti Suzuki India will be in focus on Friday after the automaker reported a marginal 0.9% year-on-year (YoY) increase in consolidated net profit to Rs 3,792 crore for Q1FY26, compared to Rs 3,760 crore in the same quarter last year. Revenue from operations rose 8% YoY to Rs 38,605 crore, up from Rs 35,779 crore a year a standalone basis, the company reported a net profit of Rs 3,712 crore, beating ET NOW's poll estimate of Rs 3,087 crore. Revenue stood at Rs 38,414 crore, above the forecast of Rs 36,288 crore. EBITDA came in at Rs 3,996 crore, compared to an estimate of Rs 3,790 the earnings beat, sequential performance showed some softness. Net profit dipped 3% quarter-on-quarter (QoQ) from Rs 3,911 crore in Q4FY25, while revenue declined 0.5% from Rs 38,605 reported a 1% YoY increase in total sales volume to 5,27,861 units during the quarter. Net sales rose 8% YoY to Rs 36,625 crore. However, operating EBIT declined 19% YoY to Rs 3,058 crore, indicating margin pressure despite revenue margin decline was attributed to adverse commodity prices, foreign exchange headwinds, increased sales promotion expenses, and new plant-related costs at the Kharkhoda greenfield facility. Segment-wise, domestic sales fell 4.5% YoY to 4,30,889 units, weighed down by a sharp 36.6% drop in Mini segment sales to 19,522 units. Exports, however, rose 37.4% YoY, helping offset weakness in domestic its earnings release, the company noted, 'In Quarter 1, the domestic passenger vehicle industry continued to witness a sluggish demand environment. For the company, a decline in domestic sales of 4.5% was compensated by robust export growth, resulting in an overall sales volume increase of 1.1%.'Nuvama raised its target price on Maruti to Rs 14,300 from Rs 13,400 and maintained a 'Buy' said Q1 EBITDA was in line with expectations and expects a revenue/EBITDA CAGR of 9%/10% over FY25–FY28E. RoIC is expected to remain strong at 50%+, and EPS estimates for FY26E and FY27E have been revised upwards by 2% and 4%, respectively. The valuation is based on 27x Sep-27E EPS and Rs 2,225/share in raised its target price to Rs 13,350 from Rs 13,155, maintaining an 'Add' warned of margin pressures due to a higher EV mix and discounting amid slowing demand, but expects improved product mix and favorable operating leverage to help. UVs are projected to comprise 41% of domestic volumes by export growth is expected through Suzuki and Toyota's global networks. FY27E margin is estimated at 9.9%, translating to an EBITDA per unit of around Rs 84,000.
